← Eichor
Study identifier: NCT07354165 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Financial Toxicity in Patients With Early-stage Breast Cancer

Condition: Breast Cancer  ·  Sponsor: National Cancer Institute, Naples

PhaseN/A
Planned participants864
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Non-profit, multicenter, prospective, observational study. This study aims to evaluate whether the articulated treatment algorithm that is now possible for early-stage breast cancer patients does produce tangible changes of financial distress over the time and whether the determinants of financial distress change their relative weight over the time.

This description comes directly from the study's public registry record.

Talk to the study team

Maria Lucia Iacovino, MD  ·  +3908117770692  ·  marialucia.iacovino@istitutotumori.na.it

Always discuss trial participation with your own doctor first.

Locations (1)

National Cancer Institute of NapoliNaples, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07354165